{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:55:34Z","timestamp":1789707334937,"version":"4.0.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s40123-024-00950-x","type":"journal-article","created":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:02:08Z","timestamp":1714521728000},"page":"1773-1781","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Protective Effect of Rho-Associated Kinase Inhibitor Eye Drops (Ripasudil) on Corneal Endothelial Cells After Cataract Surgery: A Prospective Comparative Study"],"prefix":"10.1007","volume":"13","author":[{"given":"Majed","family":"Alkharashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed M.","family":"Abusayf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9782-4070","authenticated-orcid":false,"given":"Wael","family":"Otaif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Alkharashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,30]]},"reference":[{"issue":"4","key":"950_CR1","doi-asserted-by":"publisher","first-page":"e489","DOI":"10.1016\/S2214-109X(20)30488-5","volume":"9","author":"MJ Burton","year":"2021","unstructured":"Burton MJ, Ramke J, Marques AP, et al. The Lancet Global Health Commission on global eye health: vision beyond 2020. Lancet Glob Heal. 2021;9(4):e489\u2013551. https:\/\/doi.org\/10.1016\/S2214-109X(20)30488-5.","journal-title":"Lancet Glob Heal"},{"issue":"2","key":"950_CR2","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/S40123-023-00678-0\/TABLES\/9","volume":"12","author":"J Ginel","year":"2023","unstructured":"Ginel J, Burguera N, Rocha-de-Lossada C, Pi\u00f1ero D, S\u00e1ez-Mart\u00edn A, Fern\u00e1ndez J. Economic evaluation of cataract: a systematic mapping review. Ophthalmol Ther. 2023;12(2):789\u2013807. https:\/\/doi.org\/10.1007\/S40123-023-00678-0\/TABLES\/9.","journal-title":"Ophthalmol Ther"},{"key":"950_CR3","doi-asserted-by":"publisher","first-page":"251584142110632","DOI":"10.1177\/25158414211063293","volume":"14","author":"C Akpolat","year":"2022","unstructured":"Akpolat C, Demir M, Cevher S, Ozturk SZ, Yesiltas S. The impact of phacoemulsification surgery on vision-related quality of life in senile cataract patients. Ther Adv Ophthalmol. 2022;14:251584142110632. https:\/\/doi.org\/10.1177\/25158414211063293.","journal-title":"Ther Adv Ophthalmol"},{"issue":"3","key":"950_CR4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/ICU.0000000000000951","volume":"34","author":"HJ Levin","year":"2023","unstructured":"Levin HJ, Mehta MS, Storey PP, et al. Endophthalmitis following cataract surgery: visual outcomes, microbial spectrum and complications. Curr Opin Ophthalmol. 2023;34(3):237\u201342. https:\/\/doi.org\/10.1097\/ICU.0000000000000951.","journal-title":"Curr Opin Ophthalmol"},{"issue":"4","key":"950_CR5","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/S41433-019-0575-Z","volume":"34","author":"MH Qureshi","year":"2020","unstructured":"Qureshi MH, Steel DHW. Retinal detachment following cataract phacoemulsification\u2014a review of the literature. Eye (Lond). 2020;34(4):616\u201331. https:\/\/doi.org\/10.1038\/S41433-019-0575-Z.","journal-title":"Eye (Lond)"},{"issue":"3","key":"950_CR6","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3390\/MEDICINA59030583","volume":"59","author":"AF M\u00e1rquez","year":"2023","unstructured":"M\u00e1rquez AF, Urbinati F, Rocha-de-Lossada C, et al. Management of suprachoroidal hemorrhage during phacoemulsification: a comprehensive review. Medicina (B Aires). 2023;59(3):583. https:\/\/doi.org\/10.3390\/MEDICINA59030583.","journal-title":"Medicina (B Aires)"},{"key":"950_CR7","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/1819454","author":"D Borroni","year":"2021","unstructured":"Borroni D, Rocha-De-Lossada C, Parekh M, et al. Tips, tricks, and guides in Descemet membrane endothelial keratoplasty learning curve. J Ophthalmol. 2021. https:\/\/doi.org\/10.1155\/2021\/1819454.","journal-title":"J Ophthalmol"},{"key":"950_CR8","doi-asserted-by":"publisher","first-page":"6644114","DOI":"10.1155\/2021\/6644114","volume":"2021","author":"C Rocha-De-Lossada","year":"2021","unstructured":"Rocha-De-Lossada C, Rachwani-Anil R, Borroni D, et al. New horizons in the treatment of corneal endothelial dysfunction. J Ophthalmol. 2021;2021:6644114. https:\/\/doi.org\/10.1155\/2021\/6644114.","journal-title":"J Ophthalmol"},{"issue":"2","key":"950_CR9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1358\/DOF.2013.038.02.1924778","volume":"38","author":"GD Novack","year":"2013","unstructured":"Novack GD. RHO kinase inhibitors for the treatment of glaucoma. Drugs Future. 2013;38(2):107\u201313. https:\/\/doi.org\/10.1358\/DOF.2013.038.02.1924778.","journal-title":"Drugs Future"},{"key":"950_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062095","author":"A Pipparelli","year":"2013","unstructured":"Pipparelli A, Arsenijevic Y, Thuret G, Gain P, Nicolas M, Majo F. ROCK inhibitor enhances adhesion and wound healing of human corneal endothelial cells. PLoS ONE. 2013. https:\/\/doi.org\/10.1371\/journal.pone.0062095.","journal-title":"PLoS ONE"},{"key":"950_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/S12886-020-01490-1","author":"H Tanihara","year":"2020","unstructured":"Tanihara H, Kakuda T, Sano T, Kanno T, Gunji R. Safety and efficacy of ripasudil in Japanese patients with glaucoma or ocular hypertension: 12-month interim analysis of ROCK-J, a post-marketing surveillance study. BMC Ophthalmol. 2020. https:\/\/doi.org\/10.1186\/S12886-020-01490-1.","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"950_CR12","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/J.AJPATH.2012.03.033","volume":"181","author":"N Okumura","year":"2012","unstructured":"Okumura N, Koizumi N, Ueno M, et al. ROCK inhibitor converts corneal endothelial cells into a phenotype capable of regenerating in vivo endothelial tissue. Am J Pathol. 2012;181(1):268\u201377. https:\/\/doi.org\/10.1016\/J.AJPATH.2012.03.033.","journal-title":"Am J Pathol"},{"key":"950_CR13","doi-asserted-by":"publisher","DOI":"10.1167\/TVST.10.4.18","author":"H Fujimoto","year":"2021","unstructured":"Fujimoto H, Setoguchi Y, Kiryu J. The ROCK inhibitor ripasudil shows an endothelial protective effect in patients with low corneal endothelial cell density after cataract surgery. Transl Vis Sci Technol. 2021. https:\/\/doi.org\/10.1167\/TVST.10.4.18.","journal-title":"Transl Vis Sci Technol."},{"issue":"1","key":"950_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/ICU.0000000000000121","volume":"26","author":"JW Ho","year":"2015","unstructured":"Ho JW, Afshari NA. Advances in cataract surgery: preserving the corneal endothelium. Curr Opin Ophthalmol. 2015;26(1):22\u20137. https:\/\/doi.org\/10.1097\/ICU.0000000000000121.","journal-title":"Curr Opin Ophthalmol"},{"issue":"1","key":"950_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1136\/BJO.2009.158360","volume":"95","author":"A Van Den Bruel","year":"2011","unstructured":"Van Den Bruel A, Gailly J, Devriese S, Welton NJ, Shortt AJ, Vrijens F. The protective effect of ophthalmic viscoelastic devices on endothelial cell loss during cataract surgery: a meta-analysis using mixed treatment comparisons. Br J Ophthalmol. 2011;95(1):5\u201310. https:\/\/doi.org\/10.1136\/BJO.2009.158360.","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"950_CR16","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/J.JCRS.2014.05.031","volume":"40","author":"RG Abell","year":"2014","unstructured":"Abell RG, Kerr NM, Howie AR, Kamal MAAM, Allen PL, Vote BJ. Effect of femtosecond laser-assisted cataract surgery on the corneal endothelium. J Cataract Refract Surg. 2014;40(11):1777\u201383. https:\/\/doi.org\/10.1016\/J.JCRS.2014.05.031.","journal-title":"J Cataract Refract Surg"},{"issue":"3","key":"950_CR17","first-page":"101","volume":"7","author":"M Moshirfar","year":"2018","unstructured":"Moshirfar M, Parker L, Birdsong OC, et al. Use of rho kinase inhibitors in ophthalmology: a review of the literature. Med Hypothesis, Discov Innov Ophthalmol. 2018;7(3):101.","journal-title":"Med Hypothesis, Discov Innov Ophthalmol."},{"issue":"1","key":"950_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/S10792-021-02002-W\/METRICS","volume":"42","author":"BC Saha","year":"2022","unstructured":"Saha BC, Kumari R, Kushumesh R, Ambasta A, Sinha BP. Status of rho kinase inhibitors in glaucoma therapeutics\u2014an overview. Int Ophthalmol. 2022;42(1):281\u201394. https:\/\/doi.org\/10.1007\/S10792-021-02002-W\/METRICS.","journal-title":"Int Ophthalmol"},{"issue":"7","key":"950_CR19","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1136\/BJO.2010.194571","volume":"95","author":"N Okumura","year":"2011","unstructured":"Okumura N, Koizumi N, Ueno M, et al. Enhancement of corneal endothelium wound healing by Rho-associated kinase (ROCK) inhibitor eye drops. Br J Ophthalmol. 2011;95(7):1006\u20139. https:\/\/doi.org\/10.1136\/BJO.2010.194571.","journal-title":"Br J Ophthalmol"},{"key":"950_CR20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/J.AJO.2020.12.006","volume":"224","author":"U Schl\u00f6tzer-Schrehardt","year":"2021","unstructured":"Schl\u00f6tzer-Schrehardt U, Zenkel M, Strunz M, et al. Potential functional restoration of corneal endothelial cells in Fuchs endothelial corneal dystrophy by ROCK inhibitor (ripasudil). Am J Ophthalmol. 2021;224:185\u201399. https:\/\/doi.org\/10.1016\/J.AJO.2020.12.006.","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"950_CR21","doi-asserted-by":"publisher","first-page":"3680","DOI":"10.1167\/IOVS.08-2634","volume":"50","author":"N Okumura","year":"2009","unstructured":"Okumura N, Ueno M, Koizumi N, et al. Enhancement on primate corneal endothelial cell survival in vitro by a ROCK inhibitor. Invest Ophthalmol Vis Sci. 2009;50(8):3680\u20137. https:\/\/doi.org\/10.1167\/IOVS.08-2634.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"950_CR22","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/ICU.0000000000000748","volume":"32","author":"ZA Syed","year":"2021","unstructured":"Syed ZA, Rapuano CJ. Rho kinase (ROCK) inhibitors in the management of corneal endothelial disease. Curr Opin Ophthalmol. 2021;32(3):268\u201374. https:\/\/doi.org\/10.1097\/ICU.0000000000000748.","journal-title":"Curr Opin Ophthalmol"},{"issue":"11","key":"950_CR23","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1056\/nejmoa1712770\/suppl_file\/nejmoa1712770_DISCLOSURES.PDF","volume":"378","author":"S Kinoshita","year":"2018","unstructured":"Kinoshita S, Koizumi N, Ueno M, et al. Injection of cultured cells with a ROCK inhibitor for bullous keratopathy. N Engl J Med. 2018;378(11):995\u20131003. https:\/\/doi.org\/10.1056\/nejmoa1712770\/suppl_file\/nejmoa1712770_DISCLOSURES.PDF.","journal-title":"N Engl J Med"},{"issue":"3","key":"950_CR24","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1097\/ICO.0000000000002437","volume":"40","author":"G Moloney","year":"2021","unstructured":"Moloney G, GarcerantCongote D, Hirnschall N, et al. Descemet stripping only supplemented with topical ripasudil for Fuchs endothelial dystrophy 12-month outcomes of the Sydney Eye Hospital Study. Cornea. 2021;40(3):320\u20136. https:\/\/doi.org\/10.1097\/ICO.0000000000002437.","journal-title":"Cornea"},{"key":"950_CR25","doi-asserted-by":"publisher","unstructured":"Alkharashi M, AlAbbasi O. MMPU of R-KI has BE on CE after PMEAJO 2020 J 29;26(4):246\u2013249. https:\/\/doi.org\/10.4103\/meajo.MP32153339.","DOI":"10.4103\/meajo.MP32153339"},{"key":"950_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2018.0","author":"A Achiron","year":"2018","unstructured":"Achiron A, Feldman A, Karmona L, Avizemer H, Barequet IS, Rosner M, Knyazer B, Bartov E. Burgansky Z V-DVP exposure of human corneal endothelial cells to R kinase inhibitor reduced apoptosis rate after phacoemulsification: E vivo study. JCRS. 2018. https:\/\/doi.org\/10.1016\/j.jcrs.2018.0.","journal-title":"JCRS"},{"key":"950_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000003282","author":"MFRT Tseng","year":"2023","unstructured":"Tseng MFRT. Topical ripasudil for the treatment of segmental corneal edema: a case series. Cornea. 2023. https:\/\/doi.org\/10.1097\/ICO.0000000000003282. (Epub ahead of print. PMID: 37098107).","journal-title":"Cornea"},{"key":"950_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/J.AJO.2013.05.016","author":"H Tanihara","year":"2013","unstructured":"Tanihara H, Inoue T, Yamamoto T, Kuwayama Y, Abe H, Araie M. Phase 2 randomized clinical study of a Rho kinase inhibitor, K-115, in primary open-angle glaucoma and ocular hypertension. Am J Ophthalmol. 2013. https:\/\/doi.org\/10.1016\/J.AJO.2013.05.016.","journal-title":"Am J Ophthalmol"},{"key":"950_CR29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/J.AJO.2020.04.002","volume":"217","author":"CE Wisely","year":"2020","unstructured":"Wisely CE, Liu KC, Gupta D, Carlson AN, Asrani SG, Kim T. Reticular bullous epithelial edema in corneas treated with netarsudil: a case series. Am J Ophthalmol. 2020;217:20\u20136. https:\/\/doi.org\/10.1016\/J.AJO.2020.04.002.","journal-title":"Am J Ophthalmol"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-024-00950-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-024-00950-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-024-00950-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T12:33:05Z","timestamp":1716294785000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-024-00950-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,30]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["950"],"URL":"https:\/\/doi.org\/10.1007\/s40123-024-00950-x","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,30]]},"assertion":[{"value":"12 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Majed Alkharashi, Mohammed M Abusayf, Wael Otaif and Abdullah Alkharashi declare that they have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was conducted in accordance with the ethical standards outlined by the Helsinki Declaration and was approved by the Ethical Committee at King Saud University, Riyadh, Saudi Arabia. Informed consent was obtained from all patients who were enrolled in the ophthalmology outpatient clinic between October 2021 and March 2022.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}